Bionano Genomics Inc(BNGO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 5 at 5:33 PM ET (Korea 11/6 07:33)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -3.73 | Insider Own | 5.93% | Shs Outstand | 14.0M | Perf Week | -8.33% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 54.67% | Insider Trans | 0.97% | Shs Float | 13.2M | Perf Month | -24.66% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.45 | Inst Own | 17.2% | Short Float | 10.34% | Perf Quarter | -5.17% |
| Income | -0.03B | P/S | 0.51 | EPS this Y | 67.1% | Inst Trans | 9.37% | Short Ratio | 1.46 | Perf Half Y | -17.29% |
| Sales | 0.03B | P/B | 0.41 | EPS next 5Y | 56.92% | ROA | -52.04% | Short Interest | 1.36M | Perf YTD | -28.1% |
| Book/sh | 2.68 | P/C | 1.48 | EPS past 3/5Y | 73.98% 54.05% | ROE | -83.56% | 52W High | -50.67% ($2.23) | Perf Year | -34.91% |
| Cash/sh | 0.75 | P/FCF | - | Sales past 3/5Y | 0.84% 27.37% | ROIC | -85.92% | 52W Low | 10% ($1.00) | Perf 3Y | -98.83% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 91.68% | Gross Margin | 47.5% | Volatility(W/M) | 5.91% 6.09% | Perf 5Y | -99.97% |
| Dividend TTM | - | EV/Sales | 0.39 | Sales Y/Y TTM | 10.03% | Oper. Margin | -106.67% | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.96 | EPS Q/Q | 67.74% | Profit Margin | -106.58% | RSI (14) | 33.47 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.48 | Sales Q/Q | 21.36% | SMA20 | -11.08% ($1.24) | Beta | 1.71 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.21 | Earnings | 2026/11/10 | SMA50 | -19.68% ($1.37) | Rel Volume | 0.42 | Prev Close | $1.19 |
| Employees | 97 | LT Debt/Eq | 0.18 | EPS/Sales Surpr. | 1.49% 8.2% | SMA200 | -10.96% ($1.24) | Avg Volume(3M) | 0.93M | Price | $1.1 |
| IPO | 2018/9/21 | Option/Short | No/Yes | Trades | 1136 | Volume | 394,413 | Change | -7.56% |
🧬 Bionano Genomics () is a US genomics analysis company that develops and sells the 'Saphyr' Optical Genome Mapping (OGM) system, which analyzes large-scale structural variations in DNA at high resolution. It supplies instruments and reagents to the research and clinical diagnostics fields, and is a small-cap healthcare name that has recently been trimming its cost structure and sharpening its focus on high-margin, recurring-revenue customers to improve profitability.
Over the past 1 year, on the lower side
51% below its 1-year high.
Traded less than usual. That is 42% of its average volume.
Next earnings report: November 10
4 days to go.
BNGO has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +67.1% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $51. Peers typically go for $246.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -100.0%. The S&P 500 did +56% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 17.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VXF Vanguard Extended Market Index ETF <0.01% It ranks #46 of 51 in the industry
Based on market cap of $15M.
RVP#45 Retractable Technologies Inc $17M PER - BNGO#46 Bionano Genomics Inc $15M PER - 
NXGL#47 Nexgel Inc $13M PER - 
FEMY#48 Femasys Inc $11M PER - 
CUPR#49 Cuprina Holdings (Cayman) Ltd $10M PER - 
FAQ
What kind of company is BNGO?
BNGO belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of BNGO?
The market cap of BNGO is approximately $15M, ranking 5,268 within its sector.
What is the 52-week high and low for BNGO?
BNGO has recorded a 52-week high of $2.23 and a low of $1.00.
